Preclinical studies constitute a fundamental stage in the development of medicinal products and medical technologies, during which scientific hypotheses are verified, and the safety and pharmacological profile of a potential product are assessed before the initiation of clinical trials involving humans. Our approach is based on reliable data analysis, enabling informed and strategic decision-making, minimizing risk, and optimizing the subsequent development pathway.
Our Services
Bringing together specialized knowledge and extensive experience, our team of experts conducts studies in accordance with the highest regulatory standards. We ensure effective management of the entire process – from safety assessment, toxicology, pharmacokinetics, and pharmacodynamics, to optimization of research plans, selection of appropriate experimental models, as well as development and validation of study protocols. We supervise project schedules and budgets, coordinate team activities, and ensure full compliance with regulatory requirements, including GCP and GLP. At the same time, we identify potential challenges and implement strategies for their effective resolution. We provide comprehensive preparation of documentation and reports, necessary for submission of preclinical results to regulatory authorities, enabling a smooth transition to the clinical trial phase.
